Hugh Mccoll III - 02 Aug 2023 Form 3 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role
Director
Signature
/s/ Michelle Yanez, Attorney-in-Fact for Hugh McColl, III
Issuer symbol
MIRA
Transactions as of
02 Aug 2023
Net transactions value
$0
Form type
3
Filing time
02 Aug 2023, 18:00:51 UTC
Previous filing
29 Aug 2022
Next filing
16 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MIRA Common Stock 40,000 02 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MIRA Stock Option (right to buy) 02 Aug 2023 Common Stock 20,000 $5.00 Direct F1
holding MIRA Stock Option (right to buy) 02 Aug 2023 Common Stock 10,000 $5.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested and became exercisable in full on June 15, 2022.
F2 The option vested and became exercisable in full on April 28, 2023.